1. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma
    Yan Xiang et al, 2016, Stem Cells International CrossRef
  2. In Vitro Anticancer Effect of Gedunin on Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells
    Luxmiga Tharmarajah et al, 2017, BioMed Research International CrossRef
  3. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells
    YAN-MIN LIU et al, 2015 CrossRef
  4. PKHhigh cells within clonal human nephrospheres provide a purified adult renal stem cell population
    Silvia Bombelli et al, 2013, Stem Cell Research CrossRef
  5. Research progress and prospects of markers for liver cancer stem cells
    Cheng-Pei Zhu, 2015, WJG CrossRef
  6. Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
    Germana Castelli et al, 2017, Cancers (Basel) CrossRef
  7. Ral signaling pathway in health and cancer
    Adel Rezaei Moghadam et al, 2017, Cancer Med CrossRef
  8. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma
    Ssu-Yin Yen et al, 2017, IJMS CrossRef
  9. Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
    Chunfeng Xie et al, 2019, J Exp Clin Cancer Res CrossRef
  10. Prominin-like, a homolog of mammalian CD133, suppresses dilp6 and TOR signaling to maintain body size and weight in Drosophila
    Huimei Zheng et al, 2019, The FASEB Journal CrossRef
  11. null
    Arthur Zimmermann, 2016 CrossRef
  12. Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells
    Haiyang Chen et al, 2013, Cancer Letters CrossRef
  13. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy
    Caecilia H C Sukowati et al, 2013, Expert Review of Gastroenterology & Hepatology CrossRef
  14. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
    Jonathan L. Tso et al, 2015, Mol Cancer CrossRef
  15. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1
    Hee Ju et al, 2016, Toxicology Letters CrossRef
  16. null
    Arthur Zimmermann, 2017 CrossRef
  17. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells
    Sherien M. El-Daly et al, 2020, ACAMC CrossRef
  18. null
    Doris Schneller et al, 2019 CrossRef
  19. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
    Alice Nomura et al, 2015, Oncotarget CrossRef
  20. The stem cell marker Prom1 promotes axon regeneration by down-regulating cholesterol synthesis via Smad signaling
    Jinyoung Lee et al, 2020, Proc Natl Acad Sci USA CrossRef
  21. Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133+ HepG2 liver cancer cells
    Changhao Fu et al, 2018, Oncol Lett CrossRef
  22. Salinomycin may inhibit the cancer stem‑like populations with increased chemoradioresistance that nasopharyngeal cancer tumorspheres contain
    Gong Zhang et al, 2018, Oncol Lett CrossRef
  23. null
    Johanna K. DiStefano et al, 2020 CrossRef
  24. Potential roles of stem cell marker genes in axon regeneration
    Jinyoung Lee et al, 2021, Exp Mol Med CrossRef
  25. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy
    Zahra Asadzadeh et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  26. Microvesicles – promising tiny players’ of cancer stem cells targeted liver cancer treatments: the interesting interactions and therapeutic aspects
    Cong He et al, 2021, Pharmacological Research CrossRef
  27. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.
    Rui Han et al, 2021, Sci Rep CrossRef
  28. Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity
    Zhuohong Li et al, 2021, J Cell Mol Med CrossRef
  29. Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
    Ya‐Ping Liu et al, 2021, MedComm CrossRef
  30. Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma
    Ewa Wolinska et al, 2021, Cancers CrossRef
  31. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF
    Zhenzhen Chen et al, 2021 CrossRef
  32. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro
    Yu Jin Kim et al, 2021, IJMS CrossRef
  33. MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period
    Tarana Arman et al, 2021, Toxicology CrossRef
  34. Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
    Su-Hoon Lee et al, 2016, oncol res CrossRef
  35. Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways
    Omar A. Ammar et al, 2022, Heliyon CrossRef
  36. Neurospora crassa is a potential source of anti-cancer agents against breast cancer
    Rui Han et al, 2022, Breast Cancer CrossRef